Philip Morris Stock Surges on Record Demand for Smoke-Free Products

The tobacco giant exceeded earnings expectations and reached an all-time high in shares, driven by the success of Zyn nicotine pouches and other smoke-free alternatives.

• Philip Morris International reported $9.7 billion in fourth-quarter sales, surpassing analysts' estimates of $9.4 billion.
• Adjusted earnings per share (EPS) came in at $1.55, exceeding expectations of $1.50 per share.
• Zyn nicotine pouch shipments grew by 33.4% in the U.S., with total shipments reaching nearly 165 million cans, a 42% year-over-year increase.
• The U.S. Food and Drug Administration recently approved Zyn for marketing, citing its reduced health risks compared to traditional tobacco products.
• Philip Morris provided a strong 2025 forecast, with adjusted annual EPS projected between $7.04 and $7.17, above the $7.03 analyst estimate.

4 Articles

Investopedia Sherwood News Quartz